ISSN: 2155-9554
+44 1478 350008
Jeffrey M Weinberg
Jamaica Hospital Medical Center, USA
Scientific Tracks Abstracts: J Clin Exp Dermatol Res
This 1-hour, live CME symposium at the 9th Clinical Dermatology Congress will focus on educating clinicians on the application of newer biologic therapies involved in the management of psoriasis with the goal of presenting the most beneficial and applicable information to clinical practice. The development of therapies that target underlying autoimmune inflammatory processes has changed treatment approaches in psoriatic diseases, and effective biologic agents have become available or are in advanced clinical development. The expert faculty will update learners on the immunopathology of biologic therapeutics for psoriasis, and provide an analysis of clinical trials of current and emerging therapies. In conclusion, learners will be able to better formulate personalized treatment plans that apply biologic therapeutics for patients with moderate-tosevere psoriasis.
Dr. Jeffrey M. Weinberg is an associate clinical professor of dermatology at the Mount Sinai School of Medicine in New York City. In addition, he is acting director of the Division of Dermatology at Jamaica Hospital Medical Center. Dr. Weinberg graduated from the University of Pennsylvania School of Medicine in Philadelphia and completed an internship in medicine at Columbia-Presbyterian Medical Center in New York City. He then completed a residency in dermatology at the University of Pennsylvania School of Medicine. Dr. Weinberg is a Fellow of the American Academy of Dermatology, where he has served on several committees, and a member of the Dermatology Foundation. He is a diplomate of the American Board of Dermatology. Dr. Weinberg is on the editorial board and is a Senior Editor of Cutis. He is also an Associate Editor of the Journal of the American Academy of Dermatology. He is a member of the Medical Board of the National Psoriasis Foundation. His clinical research encompasses a variety of dermatology-related topics, including studies of diagnostic methods in the evaluation of onychomycosis. He has been principal or co-investigator for several clinical trials. In addition, he has written or co-authored numerous articles for professional journals such as Cutis,the Journal of the American Academy of Dermatology, and Blood, as well as reviews, book chapters, and abstracts.